Suzhou Medsys Tech Co Ltd (603990) — Cash Flow-to-Debt Ratio
Suzhou Medsys Tech Co Ltd (603990) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥17.84 Million could theoretically repay 0% of its total liabilities (CN¥404.57 Million) in one year. Check Suzhou Medsys Tech Co Ltd (603990) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Suzhou Medsys Tech Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Suzhou Medsys Tech Co Ltd across 14 annual periods. Also explore Suzhou Medsys Tech Co Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Suzhou Medsys Tech Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Suzhou Medsys Tech Co Ltd. For market capitalisation and broader financial context, see market value of Suzhou Medsys Tech Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | CN¥-11.39 Million | CN¥2.36 Billion | ▲ +95.7% |
| 2023 | -0.11x | CN¥-316.65 Million | CN¥2.82 Billion | ▼ -160.3% |
| 2022 | 0.19x | CN¥50.51 Million | CN¥270.78 Million | ▲ +11.7% |
| 2021 | 0.17x | CN¥36.04 Million | CN¥215.86 Million | ▼ -53.4% |
| 2020 | 0.36x | CN¥100.48 Million | CN¥280.22 Million | ▲ +311.7% |
| 2019 | 0.09x | CN¥22.04 Million | CN¥253.08 Million | ▼ -56.3% |
| 2018 | 0.20x | CN¥48.67 Million | CN¥244.06 Million | ▲ +724.0% |
| 2017 | -0.03x | CN¥-6.16 Million | CN¥192.72 Million | ▼ -129.0% |
| 2016 | 0.11x | CN¥32.56 Million | CN¥295.37 Million | ▼ -27.0% |
| 2015 | 0.15x | CN¥37.54 Million | CN¥248.70 Million | ▼ -51.5% |
| 2014 | 0.31x | CN¥40.82 Million | CN¥131.16 Million | ▼ -17.7% |
| 2013 | 0.38x | CN¥32.84 Million | CN¥86.82 Million | ▲ +123.2% |
| 2012 | 0.17x | CN¥10.83 Million | CN¥63.90 Million | ▲ +464.6% |
| 2011 | -0.05x | CN¥-3.11 Million | CN¥66.81 Million | — |